HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX.
CHANTIX® (varenicline) tablets, for oral use
Initial U.S. Approval: 2006
RECENT MAJOR CHANGES
INDICATIONS AND USAGE
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
Tablets: 0.5 mg and 1 mg (3)
History of serious hypersensitivity or skin reactions to CHANTIX. (4)
WARNINGS AND PRECAUTIONS
Most common adverse reactions (>5% and twice the rate seen in placebo-treated patients) were nausea, abnormal (e.g., vivid, unusual, or strange) dreams, constipation, flatulence, and vomiting. (6)
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.